loading

Therapeuticsmd Inc Borsa (TXMD) Ultime notizie

pulisher
Oct 05, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Oct 05, 2026
pulisher
Sep 29, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 29, 2026
pulisher
Sep 28, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 28, 2026
pulisher
Sep 28, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 28, 2026
pulisher
Sep 25, 2026

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Sep 25, 2026
pulisher
Sep 24, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 24, 2026
pulisher
Sep 24, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Sep 24, 2026
pulisher
Sep 22, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 22, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 22, 2026
pulisher
Sep 21, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Sep 21, 2026
pulisher
Sep 18, 2026

Therapeuticsmd Stock Price Forecast. Should You Buy TXMD? - StockInvest.us

Sep 18, 2026
pulisher
Sep 11, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 11, 2026
pulisher
Sep 11, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 11, 2026
pulisher
Sep 08, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 08, 2026
pulisher
Sep 08, 2026

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 08, 2026
pulisher
Sep 04, 2026

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Sep 04, 2026
pulisher
Sep 02, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Sep 02, 2026
pulisher
Sep 01, 2026

TXMD Q3 2023 Earnings: EPS Misses by 154.9% as Revenue Remains at ZeroEBITDA Margin Trends - vinanet.vn

Sep 01, 2026
pulisher
Aug 31, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Aug 31, 2026
pulisher
Aug 28, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeLong Setup Ideas - vinanet.vn

Aug 28, 2026
pulisher
Aug 28, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCombination Correction - dars.gov.et

Aug 28, 2026
pulisher
Aug 28, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.22 as Traders Eye Tight Trading RangeCup and Handle - careplusvn.com

Aug 28, 2026
pulisher
Aug 27, 2026

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Aug 27, 2026
pulisher
Aug 26, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Aug 26, 2026
pulisher
Aug 25, 2026

THERAPEUTICSMD STOCK : BIG PRICE RECOVERY | TXMD STOCK Moon (nkL8YZ0GKj) - Mshale

Aug 25, 2026
pulisher
Aug 25, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 25, 2026
pulisher
Aug 24, 2026

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingAnalyst Drop Coverage - vinanet.vn

Aug 24, 2026
pulisher
Aug 24, 2026

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingPre-Announcement Alert - siam.in

Aug 24, 2026
pulisher
Aug 24, 2026

TherapeuticsMD (TXMD) Quarterly Figures: EPS Falls Short of Its Estimate under the Current Snapshot; Post-Earnings: The Stock Ends Up 0.49% in the Latest ReadingGross Profit Margin - dars.gov.et

Aug 24, 2026
pulisher
Aug 22, 2026

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordHigh Volume Node - vinanet.vn

Aug 22, 2026
pulisher
Aug 22, 2026

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordKey Reversal Day - vinanet.vn

Aug 22, 2026
pulisher
Aug 22, 2026

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordSocial Sentiment - careplusvn.com

Aug 22, 2026
pulisher
Aug 22, 2026

TherapeuticsMD (TXMD) Range: Ends a Quiet Session at $2.06 in the Latest Reading; Levels: Traders Can Monitor the $1.96-$2.16 Range in the Available RecordADD Alert - dars.gov.et

Aug 22, 2026
pulisher
Aug 21, 2026

TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionLiquidity Order Flow - vinanet.vn

Aug 21, 2026
pulisher
Aug 21, 2026

TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionDealer Gamma - siam.in

Aug 21, 2026
pulisher
Aug 21, 2026

TherapeuticsMD (TXMD) Range: Moves 0.49% Down to $2.05; the Current Price Sits Inside the Supplied Technical Range for the Current SessionVolume Spike Alerts - careplusvn.com

Aug 21, 2026
pulisher
Aug 20, 2026

TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseSegment Revenue Breakdown - vinanet.vn

Aug 20, 2026
pulisher
Aug 20, 2026

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 20, 2026
pulisher
Aug 20, 2026

TherapeuticsMD, Inc. Revenue Breakdown – NASDAQ:TXMD - TradingView

Aug 20, 2026
pulisher
Aug 20, 2026

TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseInterim Report - careplusvn.com

Aug 20, 2026
pulisher
Aug 20, 2026

TherapeuticsMD (TXMD) Results Review: The EPS Result Is Below Expectation for This Review; Post-Earnings: The Stock Records a 1.48% Increase at the CloseReturn On Equity - dars.gov.et

Aug 20, 2026
pulisher
Aug 19, 2026

TherapeuticsMD(TXMD) Stock Options Chain | Quotes & News - Moomoo

Aug 19, 2026
pulisher
Aug 18, 2026

TherapeuticsMD Company Profile & Introduction - Moomoo

Aug 18, 2026
pulisher
Aug 17, 2026

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Aug 17, 2026
pulisher
Aug 16, 2026

TherapeuticsMD, Inc. Revenue Breakdown – DUS:29TA - TradingView

Aug 16, 2026
pulisher
Aug 14, 2026

ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView

Aug 14, 2026
pulisher
Aug 13, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.08 as Traders Eye Key Support and ResistanceBull Flag - vinanet.vn

Aug 13, 2026
pulisher
Aug 13, 2026

TherapeuticsMD (TXMD) Holds Steady at $2.08 as Traders Eye Key Support and ResistanceLow Volatility Picks - dars.gov.et

Aug 13, 2026
pulisher
Aug 12, 2026

TherapeuticsMD Q2 2026 License Revenue Drops 8.7% Year Over Year - clinicaltrialvanguard.com

Aug 12, 2026
pulisher
Aug 11, 2026

TherapeuticsMD Q2 Net Income From Cont Ops US - Moomoo

Aug 11, 2026
$4.02
price down icon 1.59%
$5.33
price down icon 3.96%
$2.025
price down icon 1.22%
UPC UPC
$4.15
price down icon 0.72%
$7.89
price down icon 1.62%
$0.97
price up icon 5.57%
Capitalizzazione:     |  Volume (24 ore):